Reference:
  1. WHO Timeline-COVID 19. (2020, April27). Retrieved from https://www.who.int/news-room/detail/27-04-2020-who-timeline—covid-19
  2. American journal of emergency medicine PE case report
  3. Guan W.J., Ni Z. Y., Liang W.H., Ou C Q. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 28 Feb 2020 [Google Scholar]
  4. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama 2020.
  5. Chen G., Wu D., Cao Y., Huang D. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020 Mar 27 (pii:137244) [Google Scholar]
  6. Han H., Yang L., Liu R., Liu F., Wu K.L. Prominent changes in the blood coagulation of the patients with SARS-CoV-2 infection. Clin. Chem Lab Med (CCLM) Mar 2020 [Google Scholar]
  7. Tolouian, R., Vahed, S. Z., Ghiyasvand, S., Tolouian, A., & Ardalan, M. (2020). COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment.Journal of Renal Injury Prevention , 9 (2). doi: 10.34172/jrip.2020.19
  8. Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., … Ning, Q. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj , m1091. doi: 10.1136/bmj.m1091
  9. Poissy, J., Goutay, J., Caplan, M., Parmentier, E., Duburcq, T., Lassalle, F., … Susen, S. (2020). Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence.Circulation . doi: 10.1161/circulationaha.120.047430
  10. Tang Nig. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 27 Mar. 2020 [Google Scholar]